(Q29026436)

25 March 2017

0 references

2

Vojo Deretic

1 reference

25 March 2017

author name string

Graham S. Timmins

series ordinal

1

1 reference

25 March 2017

language of work or name

English

0 references

publication date

December 2006

1 reference

25 March 2017

published in

Molecular Microbiology

1 reference

25 March 2017

volume

62

1 reference

25 March 2017

issue

5

1 reference

25 March 2017

page(s)

1220-1227

1 reference

Crystal structure of Mycobacterium tuberculosis catalase-peroxidase

25 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

The metabolism of nitrosothiols in the Mycobacteria: identification and characterization of S-nitrosomycothiol reductase

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

Mycobacterium tuberculosis KatG is a peroxynitritase

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2958.2006.05467.X

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Protein S-nitrosylation: purview and parameters

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Oxidation of isoniazid by manganese and Mycobacterium tuberculosis catalase-peroxidase yields a new mechanism of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The oxidative environment and protein damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Nicotin-amide-adenine nucleotides of Mycobacterium tuberculosis H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

S-nitrosylation: spectrum and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid: differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Inhibition of InhA activity, but not KasA activity, induces formation of a KasA-containing complex in mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

A tutorial on the diffusibility and reactivity of free nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

NO and nitrosothiols: spatial confinement and free diffusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Mn(III) pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Enzyme-catalyzed mechanism of isoniazid activation in class I and class III peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Mycothiol-deficient Mycobacterium smegmatis mutants are hypersensitive to alkylating agents, free radicals, and antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Enzymatic and nonenzymatic superoxide-generating reactions of isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Evidence for the generation of active oxygen by isoniazid treatment of extracts of Mycobacterium tuberculosis H37Ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Peroxidase-mediated oxidation of isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Mutational and expression analysis of tbnat and its response to isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Catalase-peroxidases (KatG) exhibit NADH oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Fast-flow EPR spectroscopic observation of the isoniazid, iproniazid, and phenylhydrazine hydrazyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Metal-catalysed auto-oxidation of isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

The effects of isoniazid on the carbohydrates of Mycobacterium tuberculosis BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Molecular basis for the exquisite sensitivity of Mycobacterium tuberculosis to isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

Selective Inhibition of Nucleic Acid Synthesis in Mycobacterium tuberculosis by Isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2958.2006.05467.X

10.1111/J.1365-2958.2006.05467.X

21 January 2018

Identifiers

DOI

2 references

25 March 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17074073

1 reference

Consolidated OpenCitations Corpus – April 2017